Cargando…

Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant

BACKGROUND: Annexin A2 (ANXA2) is a pleiotropic, calcium-dependent, phospholipid-binding protein with a broad tissue distribution. It can be intracellular, membrane-bound, or secreted, and it exists as a monomer or heterotetramer. The secreted ANXA2 heterotetramer signals human and murine macrophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, Brian M., Xia, Junzhe, Epstein, Alan L., Ohlfest, John R., Chen, Wei, Blazar, Bruce R., Pennell, Christopher A., Olin, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755027/ https://www.ncbi.nlm.nih.gov/pubmed/26885373 http://dx.doi.org/10.1186/s40425-016-0112-6

Ejemplares similares

Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
por: Toussi, Deana N., et al.
Publicado: (2014)

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
por: Rammensee, Hans-Georg, et al.
Publicado: (2019)

Ligand-induced transmembrane conformational coupling in monomeric EGFR
por: Srinivasan, Shwetha, et al.
Publicado: (2022)

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
por: van den Ende, Thomas C., et al.
Publicado: (2020)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes
por: Devaraj, S., et al.
Publicado: (2009)

The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek’s disease vaccine
por: Bavananthasivam, Jegarubee, et al.
Publicado: (2018)

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
por: Abhyankar, Mayuresh M., et al.
Publicado: (2021)

Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Publicado: (2020)

Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011)

Annexin A2 in Virus Infection
por: Taylor, Julia R., et al.
Publicado: (2018)

Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling
por: Schmidinger, Barbara, et al.
Publicado: (2022)

Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain
por: Loeffler, Hannes H, et al.
Publicado: (2013)

Engineering and crystal structure of a monomeric FLT3 ligand variant
por: Pannecoucke, Erwin, et al.
Publicado: (2021)

Characterization of Chicken Thrombocyte Responses to Toll-Like Receptor Ligands
por: St. Paul, Michael, et al.
Publicado: (2012)

Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
por: Olin, Michael R, et al.
Publicado: (2014)

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
por: Dasu, Mohan R., et al.
Publicado: (2010)

Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C)
por: Schmidt, Signe Tandrup, et al.
Publicado: (2018)

Pharmacokinetics of engineered human monomeric and dimeric CH2 domains
por: Gehlsen, Kurt R., et al.
Publicado: (2012)

Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro
por: Woodham, Andrew W., et al.
Publicado: (2016)

Endogenous toll-like receptor ligands and their biological significance
por: Yu, Li, et al.
Publicado: (2010)

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies
por: Seya, Tsukasa, et al.
Publicado: (2006)

Annexin A2 and Kidney Diseases
por: Lin, Ling, et al.
Publicado: (2022)

Systemically Administered Ligands of Toll-Like Receptor 2, -4, and -9 Induce Distinct Inflammatory Responses in the Murine Lung
por: Ehrentraut, H., et al.
Publicado: (2011)

The Toll-like Receptor 2/6 Ligand MALP-2 Reduces the Viability of Mycobacterium tuberculosis in Murine Macrophages
por: Palma, Carla, et al.
Publicado: (2009)

A critical role of toll-like receptor 2 (TLR2) and its’ in vivo ligands in radio-resistance
por: Gao, Fu, et al.
Publicado: (2015)

Toll-like receptor ligands regulate the migratory pattern of leukocytes
por: Nieto, J C, et al.
Publicado: (2010)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Activation of Innate Immunity by Bacterial Ligands of Toll-Like Receptors
por: Akhmatova, Nelli K., et al.
Publicado: (2014)

Trial watch: Toll-like receptor ligands in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2023)

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
por: Choi, Chel Hun, et al.
Publicado: (2016)

The annexins
por: Moss, Stephen E, et al.
Publicado: (2004)

Role of TOLL-like Receptors in Adjuvant-Augmented Immune Therapies by T. Seya
por: Cooper, Edwin L.
Publicado: (2006)

A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
por: Xie, Daping, et al.
Publicado: (2022)

Synthesis of Enantiopure 10-Nornaltrexones in the Search for Toll-like Receptor 4 Antagonists and Opioid Ligands
por: Selfridge, Brandon R., et al.
Publicado: (2014)

Monomeric myosin anchoring
por: Wells, William A.
Publicado: (2004)

Engineering Monomeric Glycogenin
por: Dwek, David, et al.
Publicado: (2002)

Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands
por: Alfaro, Victoria Y., et al.
Publicado: (2014)

Genotoxic Agents Promote the Nuclear Accumulation of Annexin A2: Role of Annexin A2 in Mitigating DNA Damage
por: Madureira, Patricia A., et al.
Publicado: (2012)

Soluble monomeric human programmed cell death-ligand 1 inhibits the functions of activated T cells
por: Liang, Zhaoduan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ni2gqk5fu6sa28m27cvjca6qbg